Category

Mental Health

← All posts
Conditions

Ibogaine Opioid Treatment Research: What 2025-2026 Studies Found

Ibogaine opioid treatment research has moved significantly forward in 2025 and 2026, with new clinical data, a landmark $50 million Texas state investment, and a federal...

April 28, 2026 · 9 min
Executive

Psychedelic Therapy Washington DC, Maryland & Virginia: 2026 Guide

Last Updated: May 2026 If you’re looking for psychedelic therapy in Washington DC, Maryland, or Virginia (DMV), your clearest option right now is ketamine, which is...

April 27, 2026 · 8 min
Conditions

Psilocybin Alcohol Use Disorder: What Hopkins and NYU Research Found

Research on psilocybin alcohol use disorder treatment, including a landmark 2022 randomized controlled trial published in JAMA Psychiatry, has shown meaningful reductions in heavy drinking days...

April 24, 2026 · 9 min
Science & Research

Psilocybin PTSD Therapy: What the 2026 Clinical Evidence Shows

Psilocybin PTSD therapy is no longer a fringe concept. A growing body of clinical research, including Phase 2 trials published in 2025, shows that a single...

April 20, 2026 · 10 min
Conditions

The default mode network, explained: why psychedelics reset how your brain thinks

The default mode network is a cluster of brain regions responsible for self-referential thinking, rumination, and your ongoing sense of “I.” Research on default mode network...

April 16, 2026 · 9 min
Mental Health

Psychedelics for Depression: What the 2026 Research Actually Shows

Quick Answer  Psilocybin and other psychedelics show real, measurable promise for depression, particularly treatment-resistant cases. But the evidence in 2026 is more complicated, more honest, and...

March 22, 2026 · 8 min
LSD

LSD for Anxiety: What a Landmark Clinical Trial Actually Found

Quick answer: A LSD For Anxiety randomized, placebo-controlled Phase 2b trial published in JAMA found that a single oral dose of MM120, an investigational LSD formulation...

November 30, 2025 · 7 min
Legal / Policy / Geo-Legal

MDMA Therapy FDA Decision, What the Rejection Letter Means for Seekers

The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time,...

November 22, 2025 · 8 min
Guides

Ketamine Therapy Preparation: What to Expect and Why It Matters

Ketamine therapy preparation is not a formality you complete before the real thing begins. It is a functional part of what makes the treatment work. What...

August 12, 2025 · 10 min
Guides

Healing Together: Psychedelic Therapy, Partnership, and the Power of Personalized Guidance

Psychedelic guide matching is one of the most important decisions a seeker can make, and at JourneyOM, it is never left to an algorithm. This post...

July 17, 2025 · 7 min

Ready to take the next step?

Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.